In recent trading session, Precision Biosciences Inc (NASDAQ:DTIL) saw 16.49 million shares changing hands at last check today with its beta currently measuring 1.47. Company’s recent per share price level of $5.50 trading at $1.0 or 22.24% at last check today assigns it a market valuation of $42.20M. That most recent trading price of DTIL’s stock is at a discount of -253.27% from its 52-week high price of $19.43 and is indicating a premium of 34.36% from its 52-week low price of $3.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.21 million shares which gives us an average trading volume of 126.76K if we extend that period to 3-months.

For Precision Biosciences Inc (DTIL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -2.94 in the current quarter.

Precision Biosciences Inc (NASDAQ:DTIL) trade information

Upright in the green today for gaining 22.24%, in the last five days DTIL remained trading in the green while hitting it’s week-highest on Friday, 01/10/25 when the stock touched $5.50 price level, adding 26.08% to its value on the day. Precision Biosciences Inc’s shares saw a change of 44.37% in year-to-date performance and have moved 17.28% in past 5-day. Precision Biosciences Inc (NASDAQ:DTIL) showed a performance of -7.55% in past 30-days. Number of shares sold short was 0.27 million shares which calculate 2.78 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 15.5 to the stock, which implies a rise of 64.52% to its recent value today. Analysts have been projecting 1 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would jump 81.82% in reaching the projected high whereas dropping to the targeted low would mean a gain of 81.82% for stock’s current value.

Precision Biosciences Inc (DTIL) estimates and forecasts

Statistics highlight that Precision Biosciences Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -43.93% of value to its shares in past 6 months, showing an annual growth rate of 123.58% while that of industry is 16.50. Apart from that, the company came raising its revenue forecast for fiscal year 2025. This year revenue growth is estimated to rise 48.38% from the last financial year’s standing.

4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 4.28M for the same. And 1 analysts are in estimates of company making revenue of 10M in the next quarter. Company posted 7.04M and 17.58M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 7.97% during past 5 years.

Precision Biosciences Inc (NASDAQ:DTIL)’s Major holders

Insiders are in possession of 6.40% of company’s total shares while institution are holding 43.45 percent of that, with stock having share float percentage of 46.41%. Investors also watch the number of corporate investors in a company very closely, which is 43.45% institutions for Precision Biosciences Inc that are currently holding shares of the company.

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 174.93 shares of worth $0.97 million or 2.28% of the total outstanding shares. The later fund manager was in possession of 39.95 shares on Sep 30, 2024, making its stake of worth around $0.22 million in the company or a holder of 0.52% of company’s stock.